Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centro Integral Oncológico Clara Campal (CIOCC) is Spain's leading private comprehensive cancer center, integrated within the HM Hospitales group. Headquartered in Madrid, it provides a multidisciplinary approach to oncology, combining advanced clinical care with extensive translational research. CIOCC is particularly renowned for its Early Clinical Trials Unit, which is one of the most active Phase I units in Europe, offering patients access to novel therapies. The center focuses on personalized medicine, utilizing advanced diagnostics such as liquid biopsy and next-generation sequencing to tailor treatments. Through its affiliation with the HM Hospitales Research Foundation, it collaborates with major global pharmaceutical companies on a wide range of clinical trials. CIOCC's facilities include specialized units for breast, lung, gastrointestinal, and hematologic cancers, ensuring expert care across all oncological subspecialties.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centro Integral Oncología Clara Campal.